(Q41705850)

7 October 2017

title

The administration of probiotics and synbiotics in immune compromised adults: is it safe? (English)

1 reference

7 October 2017

0 references

2

1 reference

7 October 2017

3

1 reference

7 October 2017

M Van den Nieuwboer

1

1 reference

7 October 2017

L Morelli

series ordinal

4

1 reference

7 October 2017

M Cabana

series ordinal

5

1 reference

7 October 2017

E Claasen

series ordinal

6

1 reference

7 October 2017

publication date

1 March 2015

1 reference

7 October 2017

1 reference

7 October 2017

volume

6

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

3-17

1 reference

Probiotics for prevention of necrotizing enterocolitis in preterm infants

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Intestinal barrier in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Systemic cytokine response after major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Eight-year mortality associated with dental occlusion and denture use in community-dwelling elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

A porous defense: the leaky epithelial barrier in intestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Pathogenesis of HIV in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Gastrointestinal and hepatic manifestations of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Preoperative synbiotic bowel conditioning for elective colorectal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Control of pathogens and pathobionts by the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Microbial translocation in the pathogenesis of HIV infection and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Effect of probiotics on intestinal barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic, prebiotic, and synbiotic use in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Bacteriotherapy with Lactobacillus plantarum in burns

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

FAO Technical meeting on prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Treatment of inflammatory bowel disease (IBD)

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

The intestinal flora and bacterial infection in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

An update on the use and investigation of probiotics in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Predictive indices of morbidity and mortality after liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

The intestinal microbiota and host immune interactions in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Clinical trial assessing VSL#3 for the treatment of anterior resection syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic and synbiotic safety in infants under two years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

International study of the prevalence and outcomes of infection in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Regulating the safety of probiotics--the European approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotics, prebiotics, and synbiotics: gut and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Preoperative probiotics decrease postoperative infectious complications of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2014.0079

21 January 2018

Identifiers

DOI

10.3920/BM2014.0079

1 reference

7 October 2017

1 reference